Emerging Research

Emerging Role of MDM2 in Myelofibrosis Care

What is MDM2 and what does it mean for myelofibrosis patients? Watch as Dr. Srdan Verstovsek explains the mechanism of action of the MDM2 inhibitor and which patient population it may benefit.

Srdan Verstovsek, MD, PhD, Andrew Schorr

Emerging Research

MPN Researcher Shares Optimism for Future Treatment

Expert Dr. Jason Gotlib gives an overview of the progress to improve treatment durability and efficacy for MPN patients. Watch now to learn his expert knowledge.

Andrew Schorr, Jason Gotlib, MD, MS

Upcoming Events

See all events

Dec 7 2019

Saturday, December 7, 2019

ASH 2019 Daily Wraps

Join us for the first daily wrap to hear updates about the day's events from leading hematology experts. The first 45-minute live webinar will start at 6 PM Eastern (3 PM Pacific) on Saturday, December 7, with the other daily wraps on Sunday, December 8 and Monday, December 9.

Topic Area: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia , Chronic Lymphocytic Leukemia , Chronic Myelogenous Leukemia , Hodgkin Lymphoma, Mantle Cell Lymphoma, Multiple Myeloma, Myeloproliferative Neoplasms, Non-Hodgkin Lymphoma

Time: 6:00 PM – 7:00 PM Eastern Time (US and Canada)

Learn More